DK1086216T3 - Pseudo-cykliske oligonukleobaser - Google Patents
Pseudo-cykliske oligonukleobaserInfo
- Publication number
- DK1086216T3 DK1086216T3 DK00920072T DK00920072T DK1086216T3 DK 1086216 T3 DK1086216 T3 DK 1086216T3 DK 00920072 T DK00920072 T DK 00920072T DK 00920072 T DK00920072 T DK 00920072T DK 1086216 T3 DK1086216 T3 DK 1086216T3
- Authority
- DK
- Denmark
- Prior art keywords
- pcos
- segment
- oligonucleotides
- pseudo
- cyclic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6816—Hybridisation assays characterised by the detection means
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/6853—Nucleic acid amplification reactions using modified primers or templates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/31—Chemical structure of the backbone
- C12N2310/317—Chemical structure of the backbone with an inverted bond, e.g. a cap structure
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/50—Physical structure
- C12N2310/53—Physical structure partially self-complementary or closed
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Analytical Chemistry (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Plant Pathology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Enzymes And Modification Thereof (AREA)
- Saccharide Compounds (AREA)
- Eye Examination Apparatus (AREA)
- Holo Graphy (AREA)
- Magnetic Resonance Imaging Apparatus (AREA)
- Detergent Compositions (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Lubricants (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US12713899P | 1999-03-31 | 1999-03-31 | |
| US17464200P | 2000-01-05 | 2000-01-05 | |
| PCT/US2000/008826 WO2000058330A2 (en) | 1999-03-31 | 2000-03-31 | Pseudo-cyclic oligonucleobases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1086216T3 true DK1086216T3 (da) | 2003-08-18 |
Family
ID=26825372
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK00920072T DK1086216T3 (da) | 1999-03-31 | 2000-03-31 | Pseudo-cykliske oligonukleobaser |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP1086216B1 (da) |
| AT (1) | ATE241697T1 (da) |
| AU (1) | AU770615B2 (da) |
| CA (1) | CA2334707A1 (da) |
| DE (1) | DE60002967T2 (da) |
| DK (1) | DK1086216T3 (da) |
| ES (1) | ES2197868T3 (da) |
| PT (1) | PT1086216E (da) |
| WO (1) | WO2000058330A2 (da) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030099959A1 (en) * | 1995-04-12 | 2003-05-29 | Kandimalla Ekambar R. | Cooperative oligonucleotides |
| ES2646097T3 (es) * | 2009-08-27 | 2017-12-12 | Idera Pharmaceuticals, Inc. | Composición para inhibir la expresión de genes y sus usos |
| WO2012102616A1 (en) * | 2011-01-28 | 2012-08-02 | Flexgen B.V. | Heterodirectional polynucleotides |
| WO2023049275A2 (en) * | 2021-09-23 | 2023-03-30 | Arnay Sciences, Llc | Cyclic structured oligonucleotides as therapeutic agents |
| WO2024197139A2 (en) * | 2023-03-22 | 2024-09-26 | Arnay Sciences, Llc | Delivery of rna therapeutics using circular prodrug nucleic acids |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5399676A (en) * | 1989-10-23 | 1995-03-21 | Gilead Sciences | Oligonucleotides with inverted polarity |
| PL172710B1 (pl) * | 1992-07-02 | 1997-11-28 | Hybridon Inc | Samostabilizujacy sie oligonukleotyd PL PL |
| AU5741396A (en) * | 1995-05-11 | 1996-11-29 | Hybridon, Inc. | Pyrimidine targeting hairpin triplex-forming oligonucleotide s |
| US5866336A (en) * | 1996-07-16 | 1999-02-02 | Oncor, Inc. | Nucleic acid amplification oligonucleotides with molecular energy transfer labels and methods based thereon |
-
2000
- 2000-03-31 DK DK00920072T patent/DK1086216T3/da active
- 2000-03-31 AT AT00920072T patent/ATE241697T1/de not_active IP Right Cessation
- 2000-03-31 PT PT00920072T patent/PT1086216E/pt unknown
- 2000-03-31 EP EP00920072A patent/EP1086216B1/en not_active Expired - Lifetime
- 2000-03-31 ES ES00920072T patent/ES2197868T3/es not_active Expired - Lifetime
- 2000-03-31 CA CA002334707A patent/CA2334707A1/en not_active Abandoned
- 2000-03-31 AU AU40666/00A patent/AU770615B2/en not_active Ceased
- 2000-03-31 WO PCT/US2000/008826 patent/WO2000058330A2/en not_active Ceased
- 2000-03-31 DE DE60002967T patent/DE60002967T2/de not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| WO2000058330A2 (en) | 2000-10-05 |
| DE60002967D1 (de) | 2003-07-03 |
| EP1086216A2 (en) | 2001-03-28 |
| DE60002967T2 (de) | 2004-05-19 |
| PT1086216E (pt) | 2003-09-30 |
| WO2000058330A3 (en) | 2001-01-25 |
| AU4066600A (en) | 2000-10-16 |
| CA2334707A1 (en) | 2000-10-05 |
| AU770615B2 (en) | 2004-02-26 |
| ATE241697T1 (de) | 2003-06-15 |
| EP1086216B1 (en) | 2003-05-28 |
| ES2197868T3 (es) | 2004-01-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Nielsen | Peptide nucleic acid. A molecule with two identities | |
| Elayadi et al. | Implications of high-affinity hybridization by locked nucleic acid oligomers for inhibition of human telomerase | |
| KR101201664B1 (ko) | 신규한 형태의 간섭 rna 분자 | |
| RU2006126643A (ru) | Олигомерные соединения для модуляции bcl-2 | |
| DE60043149D1 (de) | -myc zielgerichtete antisenseverbindungen | |
| Bahal et al. | Nanoparticle for delivery of antisense γPNA oligomers targeting CCR5 | |
| CA2526831A1 (en) | Rna interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (sina) | |
| ATE460481T1 (de) | Verfahren zur hemmung der expression eines zielgens und medikament zur therapie einer tumorerkrankung | |
| DE69719220D1 (de) | Neue nucleotidanaloga | |
| KR20100063079A (ko) | 올리고뉴클레오티드의 탐지 방법 | |
| ATE484586T1 (de) | Synthetische doppelsträngige oligonucleotide zur gezielten hemmung der genexpression | |
| JP2005517436A5 (da) | ||
| Moccia et al. | Insights on chiral, backbone modified peptide nucleic acids: properties and biological activity | |
| Rapozzi et al. | Antigene effect in K562 cells of a PEG-conjugated triplex-forming oligonucleotide targeted to the bcr/abl oncogene | |
| WO2004078941A3 (en) | Modulation of gene expression using dna-rna hybrids | |
| CN108251420A (zh) | 抑制人和动物中CTGF基因表达的siRNA、包含其的组合物及其应用 | |
| Häner et al. | Development of artificial ribonucleases | |
| PT1175489E (pt) | Oligonucleotidos contendo uma sequencia antisense estabilizada por uma estrutura secundaria e composicoes farmaceuticas contendo as mesmas | |
| DK1086216T3 (da) | Pseudo-cykliske oligonukleobaser | |
| Lee et al. | Advantages of the circular dumbbell decoy in gene therapy and studies of gene regulation | |
| HRP20100666T1 (hr) | ANTI MIOZINSKA Va siRNA I DEPIGMENTACIJA KOŽE | |
| Pradhan et al. | Induced circular dichroism of benzo [a] pyrene-7, 8-dihydrodiol 9, 10-epoxide stereoisomers covalently bound to deoxyribooligonucleotides used to probe equilibrium distribution between groove binding and intercalative adduct conformations | |
| Opalinska et al. | Oxetane modified, conformationally constrained, antisense oligodeoxyribonucleotides function efficiently as gene silencing molecules | |
| Reddy et al. | Solid-phase synthesis of positively charged deoxynucleic guanidine (DNG) tethering a Hoechst 33258 analogue: triplex and duplex stabilization by simultaneous minor groove binding | |
| Hu et al. | Cellular localization and allele-selective inhibition of mutant huntingtin protein by peptide nucleic acid oligomers containing the fluorescent nucleobase [bis-o-(aminoethoxy) phenyl] pyrrolocytosine |